Melasma Deep Dive in Korea: Tranexamic Acid, Pico Laser, and Combination Protocols

Melasma is one of the most-treated and least-cured pigmentation conditions in Korean dermatology. The combination of hormonal influence, sun sensitivity, genetic predisposition, and inflammation makes it persistent — but well-managed. Korean dermatology has refined multimodal protocols that produce meaningful, durable improvement when patients commit to the long-term approach. This guide covers what actually works.

What melasma is

• Acquired hyperpigmentation, typically on the face — cheeks, forehead, upper lip, chin.
• Symmetric, blotchy patches of brown to gray-brown pigmentation.
• Triggered or worsened by hormonal factors (pregnancy, oral contraceptives, hormone therapy), UV exposure, visible light, heat, and certain medications.
• Three histological types: epidermal (most responsive), dermal (less responsive), and mixed.
• Affects 5–6 times more women than men; particularly common in skin types III–V.

The treatment principle

Korean dermatology consensus has converged on three rules:

• Combination beats monotherapy — single-modality treatment rarely sustains improvement.
• Sun protection is the foundation — without strict UV and visible-light protection, every other treatment will rebound.
• Patience matters — meaningful improvement takes 3–6 months, sustained protocol takes years.

The treatment toolkit

Sun protection (foundational)

• SPF 50+ broad-spectrum daily, year-round, indoor and outdoor.
• Mineral sunscreens (zinc oxide, titanium dioxide) often preferred for melasma due to visible-light protection.
• Iron oxide-tinted sunscreens block visible light, which contributes to melasma.
• Reapply every 2 hours during sun exposure.
• Hat, sunglasses, and shade-seeking behaviors as adjuncts.

Topical tranexamic acid (TXA)

• Now widely considered first-line topical treatment in Korean dermatology.
• Concentrations typically 2–5% in cream or serum.
• Inhibits melanin transfer from melanocytes to keratinocytes.
• Better safety profile than hydroquinone for long-term use.
• Often combined with niacinamide and antioxidants.

Topical hydroquinone

• Long-established melanocyte-targeting agent.
• Concentrations 2–4% (Korean OTC) to 4%+ (prescription).
• Effective but use should be cycled (typically 3–4 months on, off-period).
• Risk of exogenous ochronosis with very long unbroken use.
• Combination with retinoids and corticosteroids (Kligman\'s formula) common in stubborn cases.

Other topical agents

• Niacinamide — supports tone evenness and barrier; combines well with TXA.
• Vitamin C derivatives — antioxidant; mild brightening.
• Azelaic acid — anti-inflammatory and tyrosinase inhibition.
• Arbutin and kojic acid — alternative tyrosinase inhibitors.
• Retinoids — useful in combination but may irritate inflammation-prone melasma.

Oral tranexamic acid

• Oral TXA (typically 250–500 mg twice daily) is increasingly used in Korean dermatology for moderate-to-severe melasma.
• Studies show synergistic effect with low-fluence pico laser.
• Contraindicated in patients with thromboembolic history, hormonal contraception (relative), pregnancy.
• Requires medical evaluation before starting.
• Typical course 3–6 months with monitoring.

Low-fluence pico toning

• The most-used in-clinic procedure for melasma in Korea.
• Pico laser at very low fluence (gentle settings) at 1064 nm wavelength.
• Multiple sessions, 2–4 weeks apart.
• Combines well with oral TXA for synergistic effect.
• Lower risk of post-inflammatory hyperpigmentation than aggressive laser.

Q-switched Nd:YAG (laser toning)

• The earlier-generation predecessor of pico toning.
• Still widely used; cost-effective.
• Similar protocol — low fluence, multiple sessions.
• Comparable outcomes in many cases.

Chemical peels

• Glycolic acid, mandelic acid, salicylic acid peels in low strengths.
• Useful adjunct for surface tone evening.
• Risk of post-inflammatory hyperpigmentation if too aggressive.
• Must be combined with strict sun protection.

The Korean combination protocol

A typical 6-month Korean melasma protocol:

1. Month 0: initiate strict daily SPF 50+, topical TXA 3–5% morning, topical hydroquinone 2–4% evening (or alternative).
2. Month 1: begin low-fluence pico toning sessions every 4 weeks.
3. Month 2: add oral tranexamic acid 250–500 mg twice daily after medical clearance.
4. Months 3–4: continue protocol; assess response.
5. Months 5–6: taper hydroquinone (avoid prolonged use); maintain TXA, sun protection, pico toning.
6. Maintenance phase: indefinite sun protection, topical TXA, periodic pico toning, vigilance for triggers.

Realistic outcomes

• 50–75% improvement in MASI score (validated melasma scoring) is a typical good outcome.
• Complete clearance is rarely achieved.
• Recurrence is the rule rather than the exception without maintenance.
• Patient adherence to sun protection and topical regimen is the strongest predictor of result.

What patients underestimate

• Visible light (from screens, indoor lighting, sunny windows) contributes to melasma, not just UV.
• Heat (saunas, hot showers, exercise) can trigger melasma flare-ups.
• Hormonal contributors must be addressed where modifiable.
• Aggressive laser usually worsens melasma; gentle is the principle.
• Topical compliance over months matters more than any single in-clinic session.

What to ask in your consultation

1. What type of melasma do I have — epidermal, dermal, or mixed?
2. Are oral TXA and low-fluence pico appropriate combination for me?
3. What hormonal factors might be contributing?
4. What sun-protection regimen do you specifically recommend?
5. What is my realistic timeline — improvement and maintenance?
6. What is the protocol if I have a flare-up?

Pricing in Gangnam (2026, USD)

• Initial dermatology consultation: $80–$200.
• Low-fluence pico toning per session: $100–$280.
• Oral TXA monthly: $30–$60.
• Prescription topical (hydroquinone, TXA cream): $40–$120 per tube.
• Comprehensive 6-month protocol package: $1,200–$3,500.
• Long-term maintenance (annual): $800–$2,000 with regular pico toning.

For international patients

• Melasma is a long-term condition, not a single-trip fix.
• Korean care is most valuable for protocol design, prescription topicals, and structured pico toning sessions.
• Continuity at home country with similar dermatologist support is essential.
• Bring back prescriptions and treatment records to maintain protocol.
• Avoid aggressive laser treatment elsewhere that could rebound the condition.

Red flags

• Promises of complete melasma clearance.
• Aggressive ablative laser proposed for melasma.
• "Single treatment" approaches without maintenance.
• Lack of sun-protection education and reinforcement.
• No discussion of hormonal triggers.

The honest framing

Melasma is the dermatology condition where patient expectations and realistic outcomes most often diverge. Korean dermatology offers the right tools and protocols; patients who commit to consistent treatment over months and indefinite sun protection achieve substantial, sustained improvement. Patients chasing complete clearance are reliably disappointed. Set the expectations correctly and the long-term outcome is genuinely satisfying.